Feasibility of a Prehabilitation Intervention Among Older Adults With Myeloma Receiving Autologous Stem Cell Transplant
Status: Recruiting
Location: See location...
Intervention Type: Other, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is a pilot feasibility trial among older adults (≥60y) scheduled to undergo Autologous Stem Cell transplantation at UAB. Participants will be randomized into either a prehabilitation program or an attention control group before their transplant. The primary outcomes will be feasibility and secondary outcomes include changes in physical function at the time of transplant and at 12 weeks follow up.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 60
Healthy Volunteers: f
View:
• Diagnosis of Multiple Myeloma
• Scheduled for ASCT at UAB within 10 weeks of study enrollment
• age at ASCT ≥60y
Locations
United States
Alabama
Kirklin Clinic of UAB Hospital
RECRUITING
Birmingham
Contact Information
Primary
Landon Martin, BS
landoncmartin@uabmc.edu
205-638-2120
Backup
Noha Sharafeldin, MBBS PhD MSc
nsharafeldin@uabmc.edu
2056382120
Time Frame
Start Date: 2023-07-10
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 30
Treatments
Experimental: Teleprehab
The participants selected for the teleprehab arm will undergo a supervised 8-week multi-modal exercise program in a telehealth format (using doxy.me, a free telehealth platform) delivered by licensed physical or occupational therapists who have undergone cancer specific rehabilitation training within Select Medical's ReVital® cancer rehabilitation program. Participants will attend teleprehab sessions 2 times per week for a total of 16 sessions.
Other: Attention Control
The participants randomized to the attention control arm will not undergo an exercise regimen, but will be contacted by the study staff on the phone once a week..
Related Therapeutic Areas
Sponsors
Leads: Noha Mohamed Sharafeldin